2.1 (0.27%) 1.4 (0.18%) 
11.11 am | 23 Dec 2009 | Source: CNBC-TV18
Pharmaceutical company Lupin expects a good market share despite competition, S Ramesh, Chief Financial Officer of the company told CNBC-TV18 in an in...
1.38 pm | 24 Nov 2009 | Source: CNBC-TV18
In an interview with CNBC-TV18, S Ramesh, Chief Financial Officer of Lupin, spoke about the company and the latest developments in it. ...
2.59 pm | 09 Nov 2009 | Source: CNBC-TV18
AstraZeneca has taken Lupin to New Jersey Court over Nexium—the company’s anti-ulcer blockbuster, claiming non-infringement on 5 Nexium. In an intervi...
3.44 pm | 26 Oct 2009 | Source: CNBC-TV18
Commenting on the results, Kamal K Sharma Managing Director at Lupin said the topline grew by about 22% and profit after tax (PAT) net income stood at...
11.27 am | 24 Sep 2009 | Source: CNBC-TV18
Lupin's Rs 400 crore capex will be done through internal accruals, said it's CFO S Ramesh. ...
1.40 pm | 26 Aug 2009 | Source: CNBC-TV18
S Ramesh, Chief Financial Officer, Lupin, said, the company was looking at a capex of Rs 400 crore. Further, he said, the organic route would play a k...
8.36 pm | 30 Jul 2009 | Source: CNBC-TV18
Vineeta Gupta, Group President and CEO, Lupin, said the US Food and Drug Administration (FDA) has become vigilant in investigations and inspections of...
3.09 pm | 29 Jul 2009 | Source: CNBC-TV18
Kamal K Sharma, MD, Lupin, expects Kyowa to contribute up to 15% to the company’s topline going forward....
11.44 am | 09 Jul 2009 | Source: CNBC-TV18
The European Union (EU) is investigating several drug makers over anti trust practices. Commenting on the same, Doctor Kamal Sharma of Lupin said the ...
10.51 am | 14 May 2009 | Source: CNBC-TV18
The company said they received USFDA (US Food and Drug Administration) notice on its Mandideep facility. Commenting on the same, Kamal K Sharma, MD, L...
9.35 am | 04 Feb 2009 | Source: CNBC-TV18
Generic pharma companies have resisted the downturn but they are not entirely immune to the turbulence of the global economy. Cash-strapped companies...
4.00 pm | 29 Jan 2009 | Source: CNBC-TV18
Kamal K Sharma, Managing Director, Lupin, said in the last year same quarter they had an IP income before tax of Rs 112 crore. "So, if one takes that ...